Assisted oocyte activation does not overcome recurrent embryo developmental problems

Area of Science:

• Reproductive Medicine
• Embryology
• Genetics

Background:

• Assisted oocyte activation (AOA) using ionophores can overcome fertilization failure by inducing calcium rises.
• Its efficacy in improving embryo development after intracytoplasmic sperm injection (ICSI) in cases of recurrent developmental problems is unclear.
• Poor embryo development post-ICSI is also potentially linked to genetic defects in subcortical maternal complex (SCMC) genes.

Purpose of the Study:

• To investigate if assisted oocyte activation (AOA) can overcome recurrent embryo developmental problems after ICSI.
• To compare ICSI-AOA cycles with previous ICSI cycles in couples with normal fertilization but impaired embryonic development.

Main Methods:

• A prospective cohort study compared 17 ICSI-AOA cycles with 44 previous ICSI cycles in 42 couples.
• Methods included CaCl2 injection and ionomycin exposure for AOA, mouse oocyte calcium analysis, and genetic screening of SCMC genes and PLCZ1.

Main Results:

• ICSI-AOA cycles did not show significant improvements in blastocyst formation (13.74% vs 9.35%) or live birth rates (23.53% vs 15.91%) compared to previous ICSI cycles.
• Sperm-induced calcium patterns were normal, but genetic screening revealed variants of uncertain significance in SCMC genes and a PLCZ1 mutation in one male patient.

Conclusions:

• Assisted oocyte activation (AOA) did not enhance blastocyst formation in patients with recurrent embryo developmental problems after ICSI.
• Evidence supporting AOA for impaired embryonic development remains limited; it should be reserved for clear Ca2+-release deficiencies.
• Further genetic screening may identify novel causes and guide personalized treatment strategies.